WuXi XDC provides single-source discovery, development and manufacturing services for antibody drug conjugates (ADCs) and other novel bioconjugates. These comprehensive, integrated CRDMO services include the key intermediates, such as the chemical payload-linkers and the biologics (e.g., monoclonal, bisp...
WuXi XDC Launches New Commercial Manufacturing Facilities Aug. 11, 2023 WuXi XDC and Boostimmune Sign MOU for Integrated Services Jul. 09, 2023 WuXi Biologics Announces Proposed Spin-off and Separate Listing of WuXi XDC on the Hong Kong Stock Exchange ...
HK Stock MarketDetailed Quotes 02268 WUXI XDC Watchlist 41.900 +1.900+4.75% Not Open Mar 26 16:08 CST 50.32BMarket Cap43.56P/E (TTM) 42.250High39.550Low4.52MVolume39.550Open40.000Pre Close187.37MTurnover0.38%Turnover Ratio43.56P/E (Static)1.20BShares46.90052wk High7.02P/B50.32BFloat Cap14.08052...
Latest WuXi XDC Cayman Inc (L74:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Hong Kong, Nov. 17, 2023 –WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), congratulates its subsidiary WuXi XDC (stock code: 2268.HK), a leading global Contract Research,
SHANGHAIandSAN DIEGO,Nov. 8, 2024/PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugat...
Websitehttps://wuxixdc.com/ More ▼ Peer analysis Key Information Key Information Stock Performance Per Share Data Efficiency Management Effectiveness Profitability Financial Strength Growth Rates CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash...
WuXi XDC Cayman Inc. (Stock code: 2268) has been successfully listed on the Main board of the HKEX on 17 Nov 2023, the maximum fund raising size is HK$3,675M. WuXi XDC Cayman Inc. is a holding company primarily engaged in the provision of contract research, development and manufacturing...
WuXi XDC Cayman Inc. (Stock code: 2268) has been successfully listed on the Main board of the HKEX on 17 Nov 2023, the maximum fund raising size is HK$3,675M. WuXi XDC Cayman Inc. is a holding company primarily engaged in the provision of contract research, development and manufacturing...
603259 CNE1000031K4 Biotechnology & Medical Research End-of-day quoteShanghai S.E. 2025-04-035-day change1st Jan Change 63.52CNY-3.83% -6.30%+15.41% Apr. 02WuXi AppTec Offloads 4.23% Stake in WuXi XDC CaymanMT Apr. 02WuXi AppTec Announces Disposal Of Certain Share Assets In WuXi XDCRE...